cdmo.directory
← Compare landing

Bramble Bio vs SCTbio

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/bramble-bio/sctbio

CategoryBramble BioSCTbio
Listed sitecdmocdmo
SummaryBramble Bio specializes in cGMP manufacturing and process development for cell therapy ATIMPs, including autologous and allogeneic therapies, with 20+ years of expertise, 16 Grade B cleanrooms, and support for over 8,000 dosed patients across 46 countries.SCTbio is a European cell and gene therapy CDMO offering cGMP manufacturing, lentiviral and gammaretroviral vector production, analytical development, and QP batch release. Its facilities include 420 m² of Class A/B/C GMP cleanrooms, and it reports more than 2,000 GMP batches manufactured.
Services
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Process Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • Cold-Chain Storage & Logistics
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Lentiviral Vector Manufacturing
  • Viral Vector Manufacturing
  • Quality Control Testing
  • CMC Analytical Development
  • Process Development
  • Technology Transfer
  • Cold-Chain Storage & Logistics
  • CMC Regulatory Submission Support
Modalities
  • Cell Therapy
  • Cell Therapy
  • Gene Therapy
IndicationsData not yet provided.
  • Oncology
Locations
  • Headquarters, Europe
  • Cryopreservation & Distribution Network, Europe, Middle East, Asia (15 facilities)
  • Global Headquarters & EU Business Office, Prague, Praha, Czech Republic
  • US Business Office, Boston, MA, USA
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.